Abstract
Donepezil is one of the reversible acetylcholinesterase inhibitors which has been licensed in France since 1997 for use in patients with mild to moderate Alzheimer's disease. There is an abundant body of recently published on this molecule. This article is a review of the main papers relevant to donepezil. © 2008 Elsevier Masson SAS. All rights reserved.
Author supplied keywords
Cite
CITATION STYLE
APA
Trivalle, C. (2008). Donépézil (Aricept®). NPG Neurologie - Psychiatrie - Geriatrie, 8(44), 19–23. https://doi.org/10.1016/j.npg.2008.02.004
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free